Perrigo Company plc reported second quarter 2026 financial results for the period ended June 27, 2026. Reported diluted earnings per share were $0.63, compared to $0.00 in the prior year, driven by a $129.4 million gain on the sale of its Dermacosmetics business. Core net sales declined 3.1% year-over-year to $907 million, while core adjusted diluted EPS fell 20.7% to $0.46. The company reaffirmed its full-year 2026 outlook, projecting adjusted EPS between $2.00 and $2.30 on an All-In basis. Perrigo operates in the consumer self-care and over-the-counter health products industry.

Perrigo Company plc has finalized the employment agreement for Albert A. Manzone, who was appointed as Interim President and Chief Executive Officer, effective July 3, 2026. The agreement includes an annual base salary of $1,270,000 and a potential one-time cash bonus of $250,000 upon the expiry of his fixed term or change of control. Additionally, Mr. Manzone will receive a special restricted stock unit equity grant with a grant-date fair value of $2,500,000. Perrigo Company plc is a consumer healthcare company that provides self-care products and self-care solutions.

Perrigo Company plc reinstated its Executive Committee Severance Policy on June 29, 2026. The policy applies to all executive officers except the Interim CEO and any future successor. During a Transition Period starting June 7, 2026, and ending 12 months after a new CEO begins employment, executives facing qualifying terminations will receive 1.5 times their base salary and target bonus over 18 months, plus employer-paid COBRA premiums. Eligible participants also receive pro rata annual bonuses and career transition assistance, contingent upon signing release and restrictive covenant agreements. Perrigo Company plc is a consumer self-care company providing various over-the-counter health products.

Perrigo Company plc expanded its Board of Directors from 8 to 10 members on June 30, 2026, with the appointment of Salman Amin and Omer Gajial. Salman Amin, formerly CEO of pladis Global, joined the Audit and Nominating and Governance Committees. Omer Gajial, current CEO of GoTo Foods, joined the Talent and Compensation Committee. Both directors will receive compensation as outlined in the company's March 20, 2026, proxy statement. Perrigo Company plc is a consumer healthcare company.

Perrigo Company plc announced the immediate resignation of Patrick Lockwood-Taylor as President and Chief Executive Officer and as a member of the Board of Directors, effective June 7, 2026. The Board has appointed Albert A. Manzone as Interim President and Chief Executive Officer.